Acetamide

Acetamide

SCHEMBL6742297

CC(N)=O.CCCS(=O)(=O)O

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.43
BLM P54132 2/20 0.43
SLC6A6 P31641 1/20 0.43
CYP2C19 P33261 1/20 0.43
ALOX15 P16050 2/20 0.42
PMP22 Q01453 1/20 0.42
APP P05067 1/20 0.40
PTGS1 P23219 1/20 0.38
PDE4A P27815 1/20 0.38
ENPEP Q07075 4/20 0.35
EPHX2 P34913 1/20 0.34
TP53 P04637 1/20 0.32
ALDH1A1 P00352 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
S1PR2 O95136 1/20 0.32
S1PR1 P21453 1/20 0.32
S1PR3 Q99500 1/20 0.32
MEN1 O00255 1/20 0.30
TSHR P16473 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Urea SCHEMBL28149082 0.92 LMNA (0.46) LMNABLMSLC6A6CYP2C19ALOX15
Thioacetamide SCHEMBL6704934 0.87 LMNA (0.42) LMNABLMSLC6A6CYP2C19APP
SCHEMBL193449 0.86 TDP1 (0.52) LMNABLMSLC6A6CYP2C19APP
Methylamine SCHEMBL28108487 0.86
Acetamide SCHEMBL30416363 0.86 BLM (0.50) LMNABLMSLC6A6CYP2C19ALOX15
SCHEMBL28849565 0.86 LMNA (0.47) LMNABLMSLC6A6CYP2C19APP
SCHEMBL5268 0.86
Thiourea SCHEMBL27972110 0.84 LMNA (0.43) LMNABLMSLC6A6CYP2C19APP
SCHEMBL3381686 0.83
SCHEMBL3376538 0.83

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107428755-A Process for producing novel nitrogen-containing compound or salt thereof, and intermediate for producing the same 富士胶片株式会社 2017-12-01 CN disclosed
US-6689816-B2 SYNERGISTIC MIXTURE; THERAPY FOR PSYCHOLOGICAL DISORDERS SYNCHRONEURON 2004-02-10 US disclosed
US-20020119912-A1 Treatment of posttraumatic strees disorder, obsessive-compulsive disorder and related neuropsychiatric disorders SYNCHRONEURON INC. 2002-08-29 US disclosed
US-6391922-B1 ADMINISTERING NEUROTRANSMITTER SYNCHRONEURON, LLC 2002-05-21 US disclosed
EP-1162960-A2 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF POSTTRAUMATIC STRESS DISORDER Synchroneuron, LLC (US) 2001-12-19 EP disclosed
WO-2000056301-A2 TREATMENT OF POSTTRAUMATIC STRESS DISORDER, OBSESSIVE-COMPULSIVE DISORDER AND RELATED NEUROPSYCHIATRIC DISORDERS SYNCHRONEURON, LLC (US) 2000-09-28 WO disclosed